AI tools for systematic reviews have moved from experimental prototypes to production-ready platforms that thousands of research teams use daily. Tools like ASReview, Rayyan, Covidence, and DistillerSR now offer machine learning features for title and abstract screening, while newer platforms such as Elicit, Nested Knowledge, and large language models like ChatGPT and Claude promise to automate data extraction and even risk of bias assessment. The evidence is encouraging but uneven. A landmark study by van de Schoot et al. (2021) demonstrated that active learning can reduce screening workload by 70 to 95 percent without missing relevant studies, yet no current tool achieves the reliability needed to replace dual human screening entirely. This guide examines what actually works based on published validation studies, what Cochrane and major journals currently accept, and how to build a hybrid workflow that captures the speed of AI without sacrificing the rigor your review demands.
How AI Screening Tools Reduce Workload Without Replacing Human Reviewers
The most mature application of AI in systematic reviews is title and abstract screening, where machine learning models learn from your inclusion and exclusion decisions in real time and re-rank the remaining records by predicted relevance. This approach, called active learning, means you screen the most likely relevant records first and stop when the model predicts that the remaining unscreened records contain no further includable studies.
ASReview is the most rigorously validated open-source tool for active learning in screening. Developed at Utrecht University and published in Nature Machine Intelligence, ASReview uses a combination of feature extraction (TF-IDF or document embeddings) and classification algorithms (naive Bayes, logistic regression, or neural networks) to prioritize records. In simulation studies across multiple datasets, ASReview consistently identified 95 percent of relevant records after screening only 5 to 30 percent of the total pool. The software is free, runs locally on your machine, and produces transparent logs that document exactly which model settings were used, making it auditable for PRISMA 2020 reporting.
Rayyan integrates semi-automated screening with a collaborative web interface. Its relevance ranking algorithm learns from reviewer decisions and highlights records predicted to be relevant or irrelevant. Rayyan is widely adopted because it combines AI-assisted prioritization with manual conflict resolution features, making it practical for teams that need both speed and inter-rater reliability tracking. However, Rayyan's AI features function primarily as a recommendation layer rather than a decision-making system, which means reviewers still screen every record.
Covidence and DistillerSR occupy the premium end of the market. Covidence offers machine learning screening assistance integrated into its full review management workflow, from deduplication through data extraction to PRISMA flow diagram generation. DistillerSR provides AI-assisted screening with configurable confidence thresholds that let teams define how aggressively the model excludes records. Both platforms are subscription-based and widely used in Cochrane reviews, which lends them institutional credibility.
The critical limitation across all screening tools is that AI prioritization is not AI decision-making. Active learning reorders your screening queue to surface relevant records earlier, but the final inclusion or exclusion decision remains with the human reviewer. No major guideline body, including Cochrane, currently endorses fully automated screening where AI makes the final decision on study inclusion.
AI for Data Extraction: Where Automation Gets Harder
Data extraction is significantly more challenging to automate than screening because it requires understanding structured information within full-text PDFs, including tables, figures, supplementary materials, and varying reporting formats across journals.
Elicit uses large language models to extract study characteristics, outcomes, sample sizes, and effect estimates from research papers. You define extraction fields, upload PDFs or provide DOIs, and Elicit returns structured data with source citations pointing to specific passages. In practice, Elicit works well for extracting clearly reported fields such as study design, sample size, country, and primary outcomes. It struggles with complex statistical data reported inconsistently across studies, multi-arm trials where multiple comparisons exist within a single paper, and supplementary data not contained in the main PDF.
Nested Knowledge takes a different approach by combining AI-assisted extraction with a living evidence map that updates as new studies are added. The platform uses natural language processing to pre-populate extraction forms, which human reviewers then verify and correct. This semi-automated workflow reduces extraction time by an estimated 40 to 60 percent compared to fully manual extraction, according to the company's published benchmarks.
Semantic Scholar provides AI-powered paper discovery and extraction of key findings through its TLDR feature and structured data API. While not designed specifically for systematic review extraction, researchers use Semantic Scholar to rapidly identify study characteristics during the scoping phase and to cross-reference extracted data against indexed abstracts.
For teams building extraction templates, the practical recommendation in 2026 is to use AI extraction as a first pass that a human reviewer verifies field by field. Treating AI-extracted data as a draft rather than a final product reduces extraction time while maintaining the accuracy that peer reviewers and journals require.
AI for Risk of Bias and Quality Assessment
Risk of bias assessment, particularly using the Cochrane Risk of Bias tool (RoB 2) for randomized trials or ROBINS-I for non-randomized studies, involves nuanced judgment about study design, conduct, and reporting. AI tools are beginning to automate parts of this process, but the results remain inconsistent.
RobotReviewer, developed by researchers at the University of Bristol, uses natural language processing to automatically assess risk of bias domains for randomized controlled trials. It identifies relevant passages in full-text PDFs and classifies bias risk as low, high, or unclear for each domain. Published validation studies show that RobotReviewer achieves agreement with human assessors approximately 71 to 78 percent of the time, which is comparable to inter-rater agreement between two human reviewers. However, this accuracy drops for domains that require inference rather than identification, such as selective outcome reporting and attrition bias.
Nested Knowledge also offers AI-assisted risk of bias assessment integrated into its review workflow. The platform pre-populates bias judgments based on extracted study characteristics, which reviewers then confirm or override.
The consensus in the methodological literature is that AI can accelerate risk of bias assessment by identifying relevant text passages and suggesting preliminary judgments, but the final domain-level decisions must be made by a reviewer with methodological training. Using AI output as the sole basis for risk of bias conclusions would be flagged during peer review at most high-impact journals.
Large Language Models in Systematic Reviews: Capabilities and Boundaries
ChatGPT, Claude, and other large language models have generated intense interest for their potential to assist with multiple stages of the systematic review process, from developing search strategies to synthesizing findings. The capabilities are real but come with significant limitations that researchers must understand.
Search strategy development is one area where large language models add genuine value. You can prompt Claude or ChatGPT to generate Boolean search strings with MeSH terms, free-text synonyms, and proximity operators tailored to databases like PubMed, Embase, or CINAHL. The output requires expert review and testing, but it provides a strong starting point that reduces the time spent on iterative search refinement. Research Gold's free search strategy builder uses structured inputs to generate reproducible search strings, and combining this with large language model refinement creates an efficient workflow.
Struggling to screen thousands of records and extract data from dozens of full-text studies? Research Gold's specialist team handles the entire systematic review process, from protocol development through search execution, screening, data extraction, risk of bias assessment, meta-analysis, and manuscript writing. While AI tools can assist, nothing replaces experienced reviewers who understand your clinical question. Request a quote and let our team manage the labor-intensive stages so you can focus on interpretation and clinical implications.
Data synthesis and narrative writing is where large language models show the most visible output but carry the highest risk. ChatGPT and Claude can draft results sections, summarize study findings, and even write discussion paragraphs. The problem is that these models generate plausible text based on patterns rather than verifiable analysis. They can hallucinate study findings, invent citations, misinterpret effect directions, and produce internally consistent but factually incorrect summaries. Every sentence generated by a large language model for a systematic review must be verified against the extracted data.
Protocol and methods writing represents a lower-risk use case. Using large language models to draft PROSPERO registration text, PRISMA checklists, or methods sections based on your actual protocol decisions saves time on writing without the same verification burden as results synthesis, because the source content is your own protocol rather than external evidence.